Oral Answers to Questions

Debate between Andy Burnham and Jeff Smith

Wednesday 2nd September 2026 Commons Chamber

[The Prime Minister]

I will start with the serious point made by the right hon. Lady, which is the announcement by the German Government yesterday in relation to the attack in Leipzig. That should unite the House in sending complete condemnation of that attack by Russia, and complete solidarity to support both Germany and Ukraine, and that position will not change.

That takes me to defence. The very reason I appointed this Chancellor to his position is because of his strong commitment to the defence of our country and to defence spending. We will fully fund the defence investment plan. At the spending review we will set out a plan to meet our NATO commitments by 2035. There is no problem with our commitment to defence. More broadly, the right hon. Lady has made a lot of accusations about what went wrong, but I go back to the position that she left. The country was not heading in the right direction. Now, we are heading in the right direction. Yesterday, I laid out a clear, coherent, credible plan for growth, based on 10 years of delivering it myself. This is grounded in reality. I want to take it to all parts of the country. It is all about bringing back a sense of positivity, a sense of possibility, with growth in every postcode. Let this country believe in itself again; let people have some hope. That is what this Government will do.

[Jeff Smith (Manchester Withington) (Lab)]

Q4. There is promising and exciting evidence about the successful use of psychedelic therapy treatment for trauma, mental health, post-traumatic stress disorder and end-of-life distress. Unfortunately, as many psychedelics are schedule 1 controlled drugs, access for clinical research is bureaucratic and difficult. Will the Prime Minister, and Members across the House, consider supporting my amendments to the Health Bill that would keep safeguards in place but remove some of the barriers to some of that important research and treatment?

[The Prime Minister]

I thank my hon. Friend and pay tribute to his campaign on this issue. I was talking about getting an innovation-led economy going in all parts of the country, and that applies to research, including into life sciences. I strongly believe that we must address all barriers to high-quality research in the life sciences. I am happy to look at my hon. Friend’s amendments, and I will ask a Health Minister to meet him to discuss them. Of course, any changes must be evidence-based and proportionate and must maintain our safeguards.